Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001966716-25-000009

GENERAL COUNSEL & CORP SEC sold 3,978 shares at an average $32.28 ($128,411)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Allan Jonathan GENERAL COUNSEL & CORP SEC 2025-12-08 Sale 10b5-1 −1,300 $31.60 $41,074 14,509 D: show line 1 in the form
Allan Jonathan GENERAL COUNSEL & CORP SEC 2025-12-08 Sale 10b5-1 −2,678 $32.61 $87,337 11,831 D: show line 2 in the form
Open-market sales · 3,978 sh · avg $32.28 · $128,411
Loading xslF345X05/form4-12102025_091230.xml…